Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash & Equivalents: 2009-2025

Historic Revenue - Interest and Investment Income for Prestige Consumer Healthcare (PBH) over the last 1 years, with Mar 2010 value amounting to $791.4 million.

  • Prestige Consumer Healthcare's Cash & Equivalents rose 131.09% to $119.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.1 million, marking a year-over-year increase of 131.09%. This contributed to the annual value of $97.9 million for FY2025, which is 110.64% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Cash & Equivalents stood at $119.1 million, which was down 14.62% from $139.5 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Cash & Equivalents registered a high of $163.6 million during Q2 2021, and its lowest value of $21.0 million during Q4 2021.
  • Its 3-year average for Cash & Equivalents is $70.6 million, with a median of $58.5 million in 2023.
  • Data for Prestige Consumer Healthcare's Revenue - Interest and Investment Income shows a maximum YoY dropped of 1.24% (in 2010) over the last 5 years.
  • Prestige Consumer Healthcare's Revenue - Interest and Investment Income (Quarterly) stood at $786.6 million in 2009, then fell by 1.24% to $791.4 million in 2010.
  • Its last three reported values are $119.1 million in Q3 2025, $139.5 million for Q2 2025, and $97.9 million during Q1 2025.